PEX11α Is Required for Peroxisome Proliferation in Response to 4-Phenylbutyrate but Is Dispensable for Peroxisome Proliferator-Activated Receptor Alpha-Mediated Peroxisome Proliferation

ABSTRACT The PEX11 peroxisomal membrane proteins promote peroxisome division in multiple eukaryotes. As part of our effort to understand the molecular and physiological functions of PEX11 proteins, we disrupted the mouse PEX11α gene. Overexpression of PEX11α is sufficient to promote peroxisome division, and a class of chemicals known as peroxisome proliferating agents (PPAs) induce the expression of PEX11α and promote peroxisome division. These observations led to the hypothesis that PPAs induce peroxisome abundance by enhancing PEX11α expression. The phenotypes of PEX11α−/− mice indicate that this hypothesis remains valid for a novel class of PPAs that act independently of peroxisome proliferator-activated receptor alpha (PPARα) but is not valid for the classical PPAs that act as activators of PPARα. Furthermore, we find that PEX11α−/− mice have normal peroxisome abundance and that cells lacking both PEX11α and PEX11β, a second mammalian PEX11 gene, have no greater defect in peroxisome abundance than do cells lacking only PEX11β. Finally, we report the identification of a third mammalian PEX11 gene, PEX11γ, and show that it too encodes a peroxisomal protein.

[1]  D. Valle,et al.  PEX11β Deficiency Is Lethal and Impairs Neuronal Migration but Does Not Abrogate Peroxisome Function , 2002, Molecular and Cellular Biology.

[2]  K. Min,et al.  Regulation of lifespan by histone deacetylase , 2002, Ageing Research Reviews.

[3]  S. Gould,et al.  PEX11 promotes peroxisome division independently of peroxisome metabolism , 2002, The Journal of cell biology.

[4]  S. Benzer,et al.  Life extension in Drosophila by feeding a drug , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Philippsen,et al.  A role for Vps1p, actin, and the Myo2p motor in peroxisome abundance and inheritance in Saccharomyces cerevisiae , 2001, The Journal of cell biology.

[6]  I. J. van der Klei,et al.  Peroxisome Biogenesis and Selective Degradation Converge at Pex14p* , 2001, The Journal of Biological Chemistry.

[7]  K. Smith,et al.  Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. , 2001, Molecular genetics and metabolism.

[8]  H. Tabak,et al.  Peroxisomal membrane proteins are properly targeted to peroxisomes in the absence of COPI- and COPII-mediated vesicular transport. , 2001, Journal of cell science.

[9]  Gerbert A. Jansen,et al.  Peroxisomal fatty acid α- and β-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases , 2001 .

[10]  C. Clayton,et al.  An essential dimeric membrane protein of trypanosome glycosomes , 2001, Molecular microbiology.

[11]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[12]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[13]  T. Kirchhausen,et al.  Three ways to make a vesicle , 2000, Nature Reviews Molecular Cell Biology.

[14]  S. Gould,et al.  The genetics of peroxisome biogenesis. , 2000, Annual review of genetics.

[15]  C. Clayton,et al.  Binding of coatomer by the PEX11 C‐terminus is not required for function , 2000, FEBS letters.

[16]  H. Tabak,et al.  Pex11p Plays a Primary Role in Medium-Chain Fatty Acid Oxidation, a Process That Affects Peroxisome Number and Size in Saccharomyces cerevisiae , 2000, The Journal of cell biology.

[17]  S. South,et al.  Inhibitors of Copi and Copii Do Not Block PEX3-Mediated Peroxisome Synthesis , 2000, The Journal of cell biology.

[18]  A. Moser,et al.  Pharmacological induction of peroxisomes in peroxisome biogenesis disorders , 2000, Annals of neurology.

[19]  H. Moser Genotype-phenotype correlations in disorders of peroxisome biogenesis. , 1999, Molecular genetics and metabolism.

[20]  Daniel E. Warren,et al.  Metabolic control of peroxisome abundance. , 1999, Journal of cell science.

[21]  S. South,et al.  Peroxisome Synthesis in the Absence of Preexisting Peroxisomes , 1999, The Journal of cell biology.

[22]  H. Moser,et al.  Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls , 1999, Annals of neurology.

[23]  Y. Fujiki,et al.  cDNA cloning and characterization of a constitutively expressed isoform of the human peroxin Pex11p. , 1998, Biochemical and biophysical research communications.

[24]  C. Obie,et al.  Expression of PEX11β Mediates Peroxisome Proliferation in the Absence of Extracellular Stimuli* , 1998, The Journal of Biological Chemistry.

[25]  Igor V. Karpichev,et al.  Global Regulatory Functions of Oaf1p and Pip2p (Oaf2p), Transcription Factors That Regulate Genes Encoding Peroxisomal Proteins in Saccharomyces cerevisiae , 1998, Molecular and Cellular Biology.

[26]  K. Okumoto,et al.  Clofibrate‐inducible, 28‐kDa peroxisomal integral membrane protein is encoded by PEX11 , 1998, FEBS letters.

[27]  C. Clayton,et al.  Elongation and clustering of glycosomes in Trypanosoma brucei overexpressing the glycosomal Pex11p , 1998, The EMBO journal.

[28]  R. Urrutia,et al.  Identification and functional characterization of a novel human protein highly related to the yeast dynamin-like GTPase Vps1p. , 1998, Journal of cell science.

[29]  F. Wieland,et al.  Peroxisome Biogenesis: Involvement of ARF and Coatomer , 1998, The Journal of cell biology.

[30]  R. Wanders,et al.  Lipid metabolism in peroxisomes in relation to human disease. , 1998, Molecular aspects of medicine.

[31]  M. Hagiwara,et al.  Dymple, a Novel Dynamin-like High Molecular Weight GTPase Lacking a Proline-rich Carboxyl-terminal Domain in Mammalian Cells* , 1998, The Journal of Biological Chemistry.

[32]  B Hamilton,et al.  A heterodimer of the Zn2Cys6 transcription factors Pip2p and Oaf1p controls induction of genes encoding peroxisomal proteins in Saccharomyces cerevisiae. , 1997, European journal of biochemistry.

[33]  H. Moser,et al.  Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders , 1997, Nature Genetics.

[34]  H. Moser,et al.  The peroxisome biogenesis disorder group 4 gene, PXAAA1, encodes a cytoplasmic ATPase required for stability of the PTS1 receptor. , 1996, The EMBO journal.

[35]  H. Moser,et al.  Neuronal migration abnormality in peroxisomal bifunctional enzyme defect , 1996, Annals of neurology.

[36]  H. Saiki,et al.  The Candida boidinii peroxisomal membrane protein Pmp30 has a role in peroxisomal proliferation and is functionally homologous to Pmp27 from Saccharomyces cerevisiae , 1995, Journal of bacteriology.

[37]  D. Valle,et al.  Mice lacking ornithine–δ–amino–transferase have paradoxical neonatal hypoornithinaemia and retinal degeneration , 1995, Nature Genetics.

[38]  J. West Manipulating the Mouse Embryo . A Laboratory Manual, 2nd Edition. By Brigid Hogan, Rosa Beddington, Frank Costantini and Elizabeth Lacy. Cold Spring Harbor Laboratory Press 1994, 497 pages. Price $95. ISBN 0-87969-384-3.--- Either ISSN or Journal title must be supplied. , 1995 .

[39]  H. Moser,et al.  Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. , 1995, Journal of cell science.

[40]  J. Dyer,et al.  Pmp27 promotes peroxisomal proliferation , 1995, The Journal of cell biology.

[41]  G. Blobel,et al.  Giant peroxisomes in oleic acid-induced Saccharomyces cerevisiae lacking the peroxisomal membrane protein Pmp27p , 1995, The Journal of cell biology.

[42]  P. Watkins,et al.  Peroxisomal fatty acid β-oxidation in HepG2 cells☆ , 1991 .

[43]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[44]  G K Lewis,et al.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product , 1985, Molecular and cellular biology.

[45]  H. Bernheimer,et al.  The Cerebrohepatorenal (Zellweger) Syndrome: An Improved Method for the Biochemical Diagnosis and its Potential Value for Prenatal Detection , 1985, Pediatric Research.

[46]  H. Fahimi CYTOCHEMICAL LOCALIZATION OF PEROXIDATIC ACTIVITY OF CATALASE IN RAT HEPATIC MICROBODIES (PEROXISOMES) , 1969, The Journal of cell biology.

[47]  J. Berger,et al.  The mechanisms of action of PPARs. , 2002, Annual review of medicine.

[48]  T Hashimoto,et al.  Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. , 2001, Annual review of nutrition.

[49]  T. Hashimoto,et al.  PEROXISOMAL β-OXIDATION AND PEROXISOME PROLIFERATOR–ACTIVATED RECEPTOR α: An Adaptive Metabolic System , 2001 .

[50]  P. Vreken,et al.  Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. , 2001, Biochemical Society transactions.

[51]  D. Klionsky,et al.  Autophagy, cytoplasm-to-vacuole targeting pathway, and pexophagy in yeast and mammalian cells. , 2000, Annual review of biochemistry.

[52]  S. Subramani Components involved in peroxisome import, biogenesis, proliferation, turnover, and movement. , 1998, Physiological reviews.

[53]  W. Rizzo,et al.  Diagnosis of inborn errors of phytanic acid oxidation using tritiated phytanic acid. , 1992, Progress in clinical and biological research.